Expensify IncEXFY
Price$2.37Intrinsic value$2.7114% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $138.1M-0.8% YoYTTM through 30 Jun 2026
Net Income -$15.6MTTM through 30 Jun 2026
Free Cash Flow $12.6MTTM through 30 Jun 2026

Margins

Current
Gross Margin47.6%
EBITDA Margin-1.5%
Operating Margin-5.8%
Net Margin-11.3%

Returns

-1.7%ROE
-1.2%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio3.49x
Net Debt-$66.5Mnet cash position
Cash & Equivalents$65.8M

Quality Metrics

Altman Z-Score2.44
Piotroski F-Score4 / 9
FCF Margin9.1%
Earnings-Beat Rate25.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $142.1M
Diluted EPS-$0.17TTM
'19'20'21'22'23'24'25
FY2025: $-0.23

Dividend

No dividend

Capital Allocation

R&D Spend$20.4M
Capex Intensity0.0%

Segment Performance

No segment data available.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.